Target Name: MAP3K3
NCBI ID: G4215
Review Report on MAP3K3 Target / Biomarker Content of Review Report on MAP3K3 Target / Biomarker
MAP3K3
Other Name(s): Mitogen-activated protein kinase kinase kinase 3, transcript variant 1 | Mitogen-activated protein kinase kinase kinase 3 (isoform 1) | MAP3K3 variant 1 | MAPK/ERK kinase kinase 3 | MAPKKK3 | MAP3K3 (MEKK3) | Mitogen-activated protein kinase kinase kinase 3, transcript variant 2 | MEK kinase 3 | MAP/ERK kinase kinase 3 | Mitogen-activated protein kinase kinase kinase 3 (isoform 2) | Mitogen-activated protein kinase kinase kinase 3 | mitogen-activated protein kinase kinase kinase 3 | M3K3_HUMAN | MEKK 3 | MAP3K3 variant 2 | MEKK3

MAP3K3: A Protein Regulator of Cell Signaling and Cellular Processes

MAP3K3, also known as Mitogen-Activated Protein Kinase Kinase 3, is a protein that plays a crucial role in cellular signaling pathways. It is a key regulator of the mitotic transition, which is the process by which a cell divides and generates two daughter cells with the same number of chromosomes as the parent cell.

MAP3K3 is a protein that is expressed in almost all cell types and is involved in a wide range of cellular processes, including cell signaling, cell division, and tissue repair. It is a key regulator of the mitotic transition and is involved in the regulation of cell proliferation, differentiation, and survival.

One of the key functions of MAP3K3 is its role in the regulation of the cytoskeleton. The cytoskeleton is the structure that gives cells shape and provides support, and it is critical for the proper functioning of cells. MAP3K3 is involved in the regulation of the cytoskeleton by promoting the formation of actin filaments, which are the structural elements that make up the cytoskeleton.

Another important function of MAP3K3 is its role in the regulation of cell signaling pathways. MAP3K3 is involved in the regulation of a wide range of signaling pathways, including the signaling pathways that are responsible for cell growth, differentiation, and survival. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in the regulation of cell growth and survival.

MAP3K3 is also involved in the regulation of cell division. It is a key regulator of the G1/S transition, which is the stage of cell division where the cell prepares for cell division by producing more organelles and increasing its size. MAP3K3 is involved in the regulation of the G1/S transition by promoting the production of organelles and increasing the size of the cell.

MAP3K3 is also involved in the regulation of tissue repair. When a cell is damaged or stressed, it is often unable to repair the damage and the cell may die. MAP3K3 is involved in the regulation of tissue repair by promoting the formation of new cells and by regulating the growth of damaged cells.

Due to its involvement in so many cellular processes, MAP3K3 is a drug target that has the potential to be developed into a new drug for a variety of diseases. For example, MAP3K3 has been shown to be involved in the regulation of cancer cell growth and has been shown to be a potential target for cancer therapies. Additionally, MAP3K3 is also involved in the regulation of neurodegenerative diseases and has been shown to be involved in the regulation of the development and progression of neurodegenerative diseases.

In conclusion, MAP3K3 is a protein that plays a crucial role in cellular signaling pathways and is involved in the regulation of cell proliferation, differentiation, and survival. It is a key regulator of the mitotic transition and is involved in the regulation of the cytoskeleton, cell signaling pathways, cell division, and tissue repair. As a result, MAP3K3 has the potential to be developed into a drug target for a variety of diseases.

Protein Name: Mitogen-activated Protein Kinase Kinase Kinase 3

Functions: Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators

The "MAP3K3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAP3K3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MAP3K4 | MAP3K5 | MAP3K5-AS2 | MAP3K6 | MAP3K7 | MAP3K7CL | MAP3K8 | MAP3K9 | MAP3K9-DT | MAP4 | MAP4K1 | MAP4K1-AS1 | MAP4K2 | MAP4K3 | MAP4K3-DT | MAP4K4 | MAP4K5 | MAP6 | MAP6D1 | MAP7 | MAP7D1 | MAP7D2 | MAP7D3 | MAP9 | MAPK1 | MAPK10 | MAPK10-AS1 | MAPK11 | MAPK12 | MAPK13 | MAPK14 | MAPK15 | MAPK1IP1L | MAPK3 | MAPK4 | MAPK6 | MAPK6P2 | MAPK7 | MAPK8 | MAPK8IP1 | MAPK8IP1P2 | MAPK8IP2 | MAPK8IP3 | MAPK9 | MAPKAP1 | MAPKAPK2 | MAPKAPK3 | MAPKAPK5 | MAPKAPK5-AS1 | MAPKBP1 | MAPRE1 | MAPRE1P2 | MAPRE2 | MAPRE3 | MAPT | MAPT-AS1 | MAPT-IT1 | MARCHF1 | MARCHF10 | MARCHF11 | MARCHF11-DT | MARCHF2 | MARCHF3 | MARCHF4 | MARCHF5 | MARCHF6 | MARCHF6-DT | MARCHF7 | MARCHF8 | MARCHF9 | MARCKS | MARCKSL1 | MARCO | MARF1 | MARK1 | MARK2 | MARK2P5 | MARK2P9 | MARK3 | MARK4 | MARS1 | MARS2 | MARVELD1 | MARVELD2 | MARVELD3 | MAS1 | MAS1L | MASP1 | MASP2 | MAST1 | MAST2 | MAST3 | MAST4 | MASTL | MAT1A | MAT2A | MAT2B | MATCAP1 | MATCAP2 | MATK